MedTrace Logo

Post-operative Anemia in Lateral Fractures of the Femur.

NCT05225753 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2022-02-07

No results posted yet for this study

Summary

It was conducted a prospective study with a series of 45 patients with lateral fragility fractures of the femur treated by three different intramedullary nails. Patients were randomized in Group A (15 patients treated by Affixus Zimmer-Biomet), Group B (15 patients treated by EBA2 - Citieffe) and Group C (15 patients treated by Proximal Femoral Nail Antirotation Synthes).

One independent observer performed seven biochemical evaluations (hemoglobin serum value) from admission to patient discharge. Surgical time and Blood transfusions number were reported for each partecipant.

Conditions

  • Femur Fracture

Interventions

DIAGNOSTIC_TEST

hemoglobin serum value

post-operative anemia evaluated with hemoglobin serum value

Sponsors & Collaborators

  • Ospedali Riuniti di Foggia

    collaborator OTHER

  • Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

    lead OTHER

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2021-09-01
Completion
2021-09-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05225753 on ClinicalTrials.gov